Skip to content
Austin Top 50
Author:
Zealand Pharma
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
June 30, 2026
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
June 30, 2026
Zealand Pharma – Transactions related to share buy-back program (week 26, 2026)
June 29, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
June 22, 2026
Zealand Pharma – Transactions related to share buy-back program (week 25, 2026)
June 22, 2026
Zealand Pharma – Transactions related to share buy-back program (week 24, 2026)
June 15, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
June 10, 2026
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
June 9, 2026
Zealand Pharma – Transactions related to share buy-back program (week 23, 2026)
June 9, 2026
Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
June 9, 2026
1
2
3
4
Next Page
→